Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Cited by (1,002)

Items 501–600 of 1,002

1. Carbon ion radiotherapy as definitive treatment in non-metastasized pancreatic cancer: study protocol of the prospective phase II PACK-study
   Jakob Liermann, Patrick Naumann, Adriane Hommertgen, Moritz Pohl, Meinhard Kieser, Jürgen Debus, Klaus K Herfarth · 2020 · BMC Cancer
2. Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel
   Thomas P. Brouwer, Alexander L. Vahrmeijer, Noel F.C.C. de Miranda · 2021 · Cellular Oncology
3. Excess Body Weight and Gastrointestinal Cancer Risk
   Hans Scherübl · 2021 · Visceral Medicine
4. Inhibition of c-MET reverses radiation-induced malignant potential in pancreatic cancer
   Soichiro Mori, Hirofumi Akita, Shogo Kobayashi, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Takehiro Noda, Kunihito Gotoh, Yutaka Takeda, Masahiro Tanemura et al. · 2021 · Cancer Letters
5. ABHD11-AS1: An Emerging Long Non-Coding RNA (lncRNA) with Clinical Significance in Human Malignancies
   Upendarrao Golla, Kishore Sesham, Siva Dallavalasa, Naresh Kumar Manda, Unnam Sambamoorthy, Arun Kumar Sanapala, Sharada Nalla, Susmitha Kondam, Rajesh Kumar · 2022 · Non-Coding RNA
6. Developments in pancreatic cancer emerging therapies, diagnostic methods, and epidemiology
   Mohd Haris Jamal, MD Nasiruddin Khan · 2025 · Pathology - Research and Practice
7. The ultimate preoperative C-reactive protein-to-albumin ratio is a prognostic factor for survival after pancreatic cancer resection
   Laura van Wijk, Guus W. de Klein, Matthijs A. Kanters, Gijs A. Patijn, Joost M. Klaase · 2020 · European journal of medical research
8. Comparison of clinical usefulness of serum Ca125 and CA19-9 in pancreatic adenocarcinoma diagnosis: meta-analysis and systematic review of literature
   Aleksander Skulimowski, Adam Durczyński, Janusz Strzelczyk, Piotr Hogendorf · 2021 · Biomarkers
9. Syndecans and Pancreatic Ductal Adenocarcinoma
   Nausika Betriu, Juan Bertran-Mas, Anna Y. Andreeva, Carlos E. Semino · 2021 · Biomolecules
10. Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
    Panagiotis Sarantis, Alexandros Bokas, Adriana Papadimitropoulou, Evangelos Koustas, Stamatios E Theocharis, Pavlos Papakotoulas, Dimitriοs Schizas, Alexandros Papalampros, Evangelos S. Felekouras, Athanasios G. Papavassiliou et al. · 2021 · International Journal of Molecular Sciences
11. Extracellular Vesicles for the Diagnosis of Cancers
    Yuxiang Xue, Xue Feng, Xianfeng Fan, Guangyu Zhu, James R. McLaughlan, Wenjun Zhang, Xianfeng Chen · 2021 · Small Structures
12. iHELP: Personalised Health Monitoring and Decision Support Based on Artificial Intelligence and Holistic Health Records
    George Manias, Harm op den Akker, Ainhoa Azqueta-Alzúaz, Diego Burgos, Nikola Dino Capocchiano, Borja Llobell Crespo, Athanasios Dalianis, Andrea Damiani, Krasimir Filipov, Giorgos Giotis et al. · 2021 · IEEE Symposium on Computers and Communications (ISCC)
13. The increasing burden of pancreatic cancer in Brazil from 2000 to 2019: estimates from the Global Burden of Disease Study 2019.
    Diogo Oliveira Chaves, Aline Cândida Bastos, Alessandra Maciel Almeida, Maximiliano Ribeiro Guerra, Maria Teresa Bustamante-Teixeira, Ana Paula Souto Melo, Valéria Maria de Azeredo Passos · 2022 · Revista da Sociedade Brasileira de Medicina Tropical
14. Nanoemulsion-Assisted siRNA Delivery to Modulate the Nervous Tumor Microenvironment in the Treatment of Pancreatic Cancer
    Ling Ding, Siyuan Tang, Ao Yu, Anlin Wang, Weimin Tang, Huizhen Jia, David Oupický · 2022 · ACS Applied Materials & Interfaces
15. Gossypol Induces Apoptosis of Human Pancreatic Cancer Cells via CHOP/Endoplasmic Reticulum Stress Signaling Pathway
    Soon Lee, Eunmi Hong, Eunbi Jo, Z‐Hun Kim, Kyung June Yim, Sung Hwan Woo, Yong‐Soo Choi, Hyun‐Jin Jang · 2022 · Journal of Microbiology and Biotechnology
16. c-Myc-PD-L1 Axis Sustained Gemcitabine-Resistance in Pancreatic Cancer
    Jingjing Yao, Min Huang, Qinghong Shen, Ming Lei Ding, Shaofang Yu, Yajuan Guo, Yuefang Lin, Yaqiu Zheng, Wenbo Chen, Wenxin Yan et al. · 2022 · Frontiers in Pharmacology
17. STUDY ON THE DYNAMICS OF A PIECEWISE TUMOR–IMMUNE INTERACTION MODEL
    Sayed Saifullah, Shabir Ahmad, Fahd Jarad · 2022 · Fractals
18. Poor dental health and risk of pancreatic cancer: a nationwide registry-based cohort study in Sweden, 2009–2016
    Jingru Yu, Alexander Ploner, Margaret Chen, Ji Zhang, Gunilla Sandborgh‐Englund, Weimin Ye · 2022 · British Journal of Cancer
19. Proton Therapy, Magnetic Nanoparticles and Hyperthermia as Combined Treatment for Pancreatic BxPC3 Tumor Cells
    Francesca Brero, Paola Calzolari, Martin Albino, Antonio Antoccia, Paolo Arosio, Francesco Berardinelli, D. Bettega, Mario Ciocca, Angelica Facoetti, Salvatore Gallo et al. · 2023 · Nanomaterials
20. Cannabidiol and Cannabis Sativa as a potential treatment in vitro prostate cancer cells silenced with RBBp6 and PC3 xenograft
    Lesetja Raymond Motadi, Zodwa E. Jantjies, Boitumelo Moleya · 2023 · Molecular Biology Reports
21. Aptamer and Peptide-Engineered Polydopamine Nanospheres for Target Delivery and Tumor Perfusion in Synergistic Chemo-Phototherapy of Pancreatic Cancer
    Liang Liu, Xinyu Xiao, Jiao Guo, Jianwei Wang, Shanshan Liu, Meijiao Wang, Qiling Peng, Ning Jiang · 2023 · ACS Applied Materials & Interfaces
22. Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment
    Jesús Amo‐Aparicio, Adrian T.A. Dominguez, Shaikh Muhammad Atif, Alberto Dinarello, Tania Azam, Kibrom M. Alula, Miles Piper, Christopher Hanyoung Lieu, Robert William Lentz, Alexis Diane Leal et al. · 2023 · Cancer Research Communications
23. Neuromedin U regulates the anti‐tumor activity of CD8+ T cells and glycolysis of tumor cells in the tumor microenvironment of pancreatic ductal adenocarcinoma in an NMUR1‐dependent manner
    Rui Zheng, Si Wang, Jia Wang, Mengnan Zhou, Qi Wu Shi, Beixing Liu · 2023 · Cancer Science
24. Single-Cell Untargeted Lipidomics Using Liquid Chromatography and Data-Dependent Acquisition after Live Cell Selection
    Johanna von Gerichten, Kyle D. G. Saunders, Anastasia Kontiza, Carla F. Newman, George Mayson, Dany J. V. Beste, Eirini G. Velliou, Anthony David Whetton, Melanie Jane Bailey · 2024 · Analytical Chemistry
25. Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile
    Camilla Pecoraro, Daniela Carbone, Fabio Scianò, Francesca Terrana, Geng Xu, Cecilia Bergonzini, Margot S. F. Roeten, Stella Cascioferro, Girolamo Cirrincione, Patrizia Diana et al. · 2024 · Journal of drug targeting
26. Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreatic cancer cells
    Aimin Cai, Hailun Zheng, Zhiwei Chen, Xinlu Lin, Chen Li, Qing Yao, Yangzom Doma Bhutia, Vadivel Ganapathy, Ruijie Chen, Longfa Kou · 2020 · Biochemical Journal
27. New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial
    Dóra Illés, Emese Ivány, Gábor Holzinger, Klára Kosár, Mariette Adam, Beate Kamlage, Gábor Zsóri, Máté Tajti, Márk M. Svébis, Viktor József Horváth et al. · 2020 · BMJ Open
28. Development of a Soft Robot Based Photodynamic Therapy for Pancreatic Cancer
    Yucheng Li, Yang Liu, Kashu Yamazaki, Mingfeng Bai, Yue Chen · 2021 · IEEE/ASME Transactions on Mechatronics
29. Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
    Ntombikayise Xelwa, Geoffrey Patrick Candy, John WS Devar, J. Omoshoro–Jones, Martin Smith, Ekene Emmanuel Nweke · 2021 · Frontiers in Oncology
30. Pancreatic cancer grading in pathological images using deep learning convolutional neural networks
    Muhammad Nurmahir Mohamad Sehmi, Mohammad Faizal Ahmad Fauzi, Wan Siti Halimatul Munirah Wan Ahmad, Elaine Wan Ling Chan · 2021 · F1000Research
31. Attenuation of Pancreatic Cancer In Vitro and In Vivo via Modulation of Nrf2 and NF-κB Signaling Pathways by Natural Compounds
    Marta Cykowiak, Robert Kleszcz, Małgorzata Kucińska, Jarosław Paluszczak, Hanna Szaefer, Adam Plewiński, Hanna Piotrowska‐Kempisty, Marek Murias, Violetta Krajka‐Kuźniak · 2021 · Cells
32. MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)
    Matea Pavic, Maximilian Niyazi, L. Wilke, Stefanie Corradini, Marlies Vornhülz, Ulrich Mansmann, Amani Al Tawil, Ralph Fritsch, Juliane Hörner‐Rieber, Jürgen Debus et al. · 2022 · Radiation Oncology
33. Targeting the Endocannabinoidome in Pancreatic Cancer
    Valerio Falasca, Marco Falasca · 2022 · Biomolecules
34. Minimally Invasive Pancreaticoduodenectomy in Elderly versus Younger Patients: A Meta-Analysis
    Roberto Ballarin, Giuseppe Esposito, Gian Piero Guerrini, Paolo Magistri, Barbara Catellani, Cristiano Guidetti, Stefano Di Sandro, Fabrizio Di Benedetto · 2024 · Cancers
35. Helicobacter pylori and Gastrointestinal Cancers: Recent Advances and Controversies
    Chuandong Zhang, Yuqi Chen, Yan Long, Huimin Zheng, Jiyong Jing, Wensheng Pan · 2024 · Clinical Medicine Insights Oncology
36. Metformin's anticancer odyssey: Revealing multifaceted mechanisms across diverse neoplastic terrains- a critical review
    Rashmi Saxena Pal, Talha Jawaid, Md. Azizur Rahman, Rakesh Kumar Verma, Pratap Kumar Patra, Sharma Vedika Vijaypal, Yogendra Pal, Rohit Upadhyay · 2025 · Biochimie
37. Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression
    Gonçalo Mesquita, Natalia B. Prevarskaya, Albrecht Schwab, V’yacheslav Lehen’kyi · 2021 · Cells
38. Valosin-Containing Protein Stabilizes Mutant p53 to Promote Pancreatic Cancer Growth
    Jieqiong Wang, Yajie Chen, Canhua Huang, Qian Hao, Shelya X. Zeng, Sara Omari, Yu Zhang, Xiang Yu Zhou, Hua Lu · 2021 · Cancer Research
39. Effectiveness of Carbon Ion Radiation in Locally Advanced Pancreatic Cancer
    Jakob Liermann, Patrick Naumann, Fabian Weykamp, Philipp Hoegen, Jürgen Debus, Klaus K Herfarth · 2021 · Frontiers in Oncology
40. TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC
    Meena U. Rajagopal, Shivani Bansal, Prabhjit Kaur, Shreyans Kumar Jain, Tatiana Altadill, Charles P. Hinzman, Yaoxiang Li, Joanna Moulton, Baldev B. Singh, Sunil Bansal et al. · 2021 · Cancers
41. Comparison of endoscopic ultrasonography with and without contrast enhancement for characterization of pancreatic tumors: a meta-analysis
    Yasunobu Yamashita, Toshio Shimokawa, Reiko Ashida, Bertrand Napoléon, Andrea Lisotti, Pietro Fusaroli, Rodica Gincul, Christoph Frank Dietrich, Shunsuke Omoto, Masayuki Kitano · 2022 · Endoscopy International Open
42. Generation of a poly-functionalized indolizine scaffold and its anticancer activity in pancreatic cancer cells
    Yechan Lee, Dirgha Raj Joshi, Wan Namkung, Ikyon Kim · 2022 · Bioorganic Chemistry
43. Nal-IRI/5-FU/LV versus modified FOLFIRINOX and FOLFIRI as second-line chemotherapy for unresectable pancreatic cancer: A single center retrospective study
    Shun Tezuka, Makoto Ueno, Satoshi Kobayashi, Tomomi Hamaguchi, Yui Yamachika, Ritsuko Oishi, Shuhei Nagashima, Taito Fukushima, Manabu Morimoto, Maeda Shin · 2022 · Pancreatology
44. Average treatment effect of facility hepatopancreatobiliary cancer volume on survival of non-resected pancreatic adenocarcinoma
    Mohamedraed Elshami, Fasih Ali Ahmed, Hanna H. Kakish, Jonathan J. Hue, Richard S. Hoehn, Luke Daniel Rothermel, David Lawrence Bajor, Amr Mohamed, Jennifer Eva Selfridge, John Brian Ammori et al. · 2022 · HPB
45. Enhanced endoscopic ultrasound imaging for pancreatic lesions: The road to artificial intelligence
    Marco Spadaccini, Glenn Koleth, James Emmanuel, Kareem Khalaf, Antonio Facciorusso, Fabio Grizzi, Cesare Hassan, Matteo Colombo, Benedetto Mangiavillano, Alessandro Fugazza et al. · 2022 · World Journal of Gastroenterology
46. Laser Capture Microdissection: A Gear for Pancreatic Cancer Research
    Bhavana Hemantha Rao, Pavel Souček, Viktor Hlaváč · 2022 · International Journal of Molecular Sciences
47. Polarization of Cancer-Associated Macrophages Maneuver Neoplastic Attributes of Pancreatic Ductal Adenocarcinoma
    Huey-Jen L. Lin, Yingguang Liu, Kailey P. Caroland, Jiayuh Lin · 2023 · Cancers
48. Esculetin unveiled: Decoding its anti‐tumor potential through molecular mechanisms—A comprehensive review
    Md. Rezoan Hossain, Fatema Tuj Zahra Shova, Munni Akter, Md. Shahporan Shuvo, Nasim Ahmed, Afroza Akter, Munira Haque, Umme Salma, Md. Roman Mogal, Hasi Rani Saha et al. · 2023 · Cancer Reports
49. The Global Burden of Early-Onset Pancreatic Cancer and Its Risk Factors
    Pojsakorn Danpanichkul, Kanokphong Suparan, Aunchalee Jaroenlapnopparat, Natchaya Polpichai, Panisara Fangsaard, Areeya Detboon, Pinyada Moolkaew, Adivitch Sripusanapan, Karan Srisurapanont, Yatawee Kanjanakot et al. · 2024 · Pancreas
50. Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer
    Siyu Zhou, Baian Tao, Yujie Guo, Jichun Gu, Hengchao Li, Caifeng Zou, Sichong Tang, Shu‐Heng Jiang, Deliang Fu, Ji Li · 2024 · Journal of Translational Medicine
51. Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer
    Angela L. Hughson, Gary Hannon, Noah Salama, Tara G Vrooman, Caroline A. Stockwell, Bradley N. Mills, Jesse Garrett-Larsen, Haoming Qiu, Roula Katerji, Lauren Benoodt et al. · 2024 · Molecular Therapy — Nucleic Acids
52. A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene
    Cavin Wong, Fei Chen, Najmeh Alirezaie, Yifan Wang, Adeline Cuggia, Ayelet Borgida, Spring Holter, Tatiana Lenko, Céline Domecq, Alzheimer’s Disease Neuroimaging Initiative et al. · 2019 · PLoS Genetics
53. Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
    Natalia Gabło, Karolína Trachtová, Vladimír Procházka, Jan Hlavsa, Tomáš Grolich, Igor Kišš, Josef Srovnal, Alona Řehulková, Martin Loveček, Pavel Skalický et al. · 2020 · Journal of Clinical Medicine
54. The Role of Interleukin-6 and Inflammatory Cytokines in Pancreatic Cancer-Associated Depression
    Maria Daniela Jarrin Jara, Avneesh S Gautam, Venkata Sri Ramani Peesapati, Mohammad Sadik, Safeera Khan · 2020 · Cureus
55. PARP inhibition in treatment of pancreatic cancer
    Pascal R. Hammel, Chen Zhang, Julia Matile, Elise Colle, Imène Hadj-Naceur, Marie-Pauline Gagaille, Mohamed Bouattour, Jerome F. Cros, Louis de Mestier, Michele Lamuraglia · 2020 · Expert Review of Anticancer Therapy
56. Primary Granulocyte Colony-Stimulating Factor Prophylaxis in Metastatic Pancreatic Cancer Patients Treated with FOLFIRINOX as the First-Line Treatment
    Jae Hyup Jung, Dong Woo Shin, Jaihwan Kim, Jong-Chan Lee, Jin‐Hyeok Hwang · 2020 · Cancers
57. Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy
    Yasuhito Hagiwara, Shigeru Yamada, Yuka Isozaki, Hirotoshi Takiyama, Makoto Shinoto, Shohei Kawashiro, Tapesh Bhattacharyya, Kenji Nemoto, Hiroshi Tsuji · 2020 · Clinical and Translational Radiation Oncology
58. Treatment With Mifepristone Allows a Patient With End-stage Pancreatic Cancer in Hospice on a Morphine Drip to Restore a Decent Quality of Life
    Jerome H. Check, DIANE L. CHECK, Maya Devi Srivastava, Trina Poretta, James K. Aikins · 2020 · Anticancer Research
59. Projected economic burden of pancreatic cancer in Sweden in 2030
    Tomasz Draus, Daniel Ansari, Filip Wikström, Ulf Persson, Roland E. Andersson · 2021 · Acta Oncologica
60. Protein intake after the initiation of chemotherapy is an independent prognostic factor for overall survival in patients with unresectable pancreatic cancer: A prospective cohort study
    Yoko Hasegawa, Hideaki Ijichi, Kei Saito, Kazunaga Ishigaki, Maki Takami, Rie Sekine, Satoshi Usami, Yousuke Nakai, Kazuhiko Koike, Naoto Kubota · 2021 · Clinical Nutrition
61. Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives
    Lisa Lellouche, Lola‐Jade Palmieri, Solène Dermine, Catherine Brézault, Stanislas Chaussade, Romain Coriat · 2021 · Therapeutic Advances in Medical Oncology
62. Statin Exposure and Pancreatic Cancer Incidence: A Japanese Regional Population-Based Cohort Study, the Shizuoka Study
    Kohei Saito, Yoko Sato, Eiji Nakatani, Hideaki Kaneda, Seiichiro Yamamoto, Yoshiki Miyachi, Hiroshi Itoh · 2021 · Cancer Prevention Research
63. Induction of pancreatic neoplasia in the KRAS / TP53 Oncopig
    Pinaki Mondal, Neesha S. Patel, Katie Bailey, Shruthishree Aravind, Sara Cartwright, Michael Anthony Hollingsworth, Audrey J. Lazenby, Mark A. Carlson · 2022 · Disease Models & Mechanisms
64. Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
    Inês Mendes, Nuno Vale · 2024 · Biomedicines
65. Inflammatory markers in predicting survival in pancreatic cancer: A Systematic review and Meta-Analysis
    Rinrada Worapongpaiboon, Noppachai Siranart, Patavee Pajareya, Somkiat Phutinart · 2025 · Pancreatology
66. Glucose-6-phosphate dehydrogenase (G6PD) shields pancreatic cancer from autophagy-dependent ferroptosis by suppressing redox imbalance induced AMPK/mTOR signaling
    K. Deepak, Pritam Roy, Abhijit Das, Budhaditya Mukherjee, Mahitosh Mandal · 2025 · Free Radical Biology and Medicine
67. Simple Serum Pancreatic Ductal Adenocarcinoma (PDAC) Protein Biomarkers—Is There Anything in Sight?
    Monika Kapszewicz, Ewa Małecka-Wojciesko · 2021 · Journal of Clinical Medicine
68. Analysis of levels and Clinical value of CA19-9, NLR and SIRI in patients with Pancreatic Cancer with different Clinical Features
    Li Min, Ziyu Dong, Zhang Xiaofei, Xue Shunhe, Wang Bolin · 2022 · Cellular and Molecular Biology
69. Carcinoma-associated fibroblasts release microRNA-331-3p containing extracellular vesicles to exacerbate the development of pancreatic cancer via the SCARA5-FAK axis
    Yadong Han, Qian Xu, Teng Xu, Yang Shi · 2022 · Cancer Biology & Therapy
70. The Influence of MicroRNA-31 on Oxidative Stress and Radiosensitivity in Pancreatic Ductal Adenocarcinoma
    Jason McGrath, Laura E. Kane, Stephen G. Maher · 2022 · Cells
71. Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors: A propensity score-matched study with competing risk analysis
    Oscar Hou In Chou, Jiandong Zhou, Jonathan V Mui, Danish Iltaf Satti, Cheuk To Chung, Teddy Tai Loy Lee, Sharen Lee, Edward Christopher Dee, Kenrick Ng, Bernard M.Y. Cheung et al. · 2022 · Diabetes Epidemiology and Management
72. Geographical Distribution of Pancreatic Cancer in the State of Mississippi by Incidence and Mortality From 2003 to 2019
    Basil N Nduma, Solomon Ambe, Chukwuyem Ekhator, Ekokobe Fonkem · 2022 · Cureus
73. Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy
    Praveen Bhoopathi, Padmanabhan Mannangatti, Swadesh Kumar Das, Paul B. Fisher, Luni Emdad · 2023 · Advances in cancer research
74. Pancreatic duct imaging during aging
    Kathleen Möller, Christian Jenssen, A Ignee, Michael Hocke, Siegbert Faiss, Julio Iglesias‐García, Siyu Sun, Yi Dong, Christoph F. Dietrich · 2023 · Endoscopic Ultrasound
75. Evaluation of cell membrane-derived nanoparticles as therapeutic carriers for pancreatic ductal adenocarcinoma using an in vitro tumour stroma model
    Christos Tapeinos, Giulia Torrieri, Shiqi Wang, João Pedro Martins, Hélder A. Santos · 2023 · Journal of Controlled Release
76. Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges
    Mundla Srilatha, Rama Rao Malla, Megha Priya Adem, Jeremy B. Foote, Ganji Purnachandra Nagaraju · 2023 · Seminars in Cancer Biology
77. Green synthesis of gold and silver nanoparticles as antidiabetic and anticancerous agents
    Muhammad Asam Raza, Umme Farwa, Muhammad Waseem Mumtaz, Javeria Kainat, Areej Sabir, Abdullah Godran Al-Sehemi · 2023 · Green Chemistry Letters and Reviews
78. Meta‐analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease
    Mohammad Zamani, Shaghayegh Alizadeh‐Tabari, Mohammad Hassan Murad, Ashwin N. Ananthakrishnan, Reza Malekzadeh, Nicholas Joseph Talley · 2024 · Alimentary Pharmacology & Therapeutics
79. Theranostic nanoparticles for detection and treatment of pancreatic cancer
    Happy Agarwal, Ryan C. Bynum, Nada Saleh, Danielle Harris, William M. MacCuaig, Vung Kim, Emma J. Sanderson, Isabel S. Dennahy, Rohit Singh, Bahareh Behkam et al. · 2024 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
80. Imaging and Management of Pancreatic Cancer
    Mariya Kobi, Gregory R. Veillette, Roshni Narurkar, David Sadowsky, Viktoriya Paroder, Chaitanya Shilagani, Anthony G. Gilet, Milana Flusberg · 2019 · Seminars in Ultrasound CT and MRI
81. Tumor Regression Grading Assessment in Locally Advanced Pancreatic Cancer After Neoadjuvant FOLFIRINOX: Interobserver Agreement and Prognostic Implications
    Andrea Cacciato Insilla, Caterina Vivaldi, Mirella Giordano, Enrico Vasile, Carla Cappelli, Emanuele F. Kauffmann, Niccolò Napoli, Alfredo Falcone, Ugo Boggi, Daniela Campani · 2020 · Frontiers in Oncology
82. The role of asparagine synthetase on nutrient metabolism in pancreatic disease
    Cheng‐Yu Tsai, Michael S. Kilberg, Sohail Z. Husain · 2020 · Pancreatology
83. Multivisceral resection for adenocarcinoma of the pancreatic body and tail—a retrospective single-center analysis
    Oliver Beetz, Akin Sarisin, Alexander Kaltenborn, Jurgen L. Klempnauer, Michael Winkler, Gerrit Grannas · 2020 · World Journal of Surgical Oncology
84. Dual Delivery of Gemcitabine and Paclitaxel by Wet‐Spun Coaxial Fibers Induces Pancreatic Ductal Adenocarcinoma Cell Death, Reduces Tumor Volume, and Sensitizes Cells to Radiation
    Samantha J. Wade, Zeliha Sahin, Ann‐Katrin Piper, Sepehr Talebian, Morteza Aghmesheh, Javad Foroughi, Gordon G. Wallace, Simon E. Moulton, Kara L. Vine · 2020 · Advanced Healthcare Materials
85. Role of different immune cells and metabolic pathways in modulating the immune response in pancreatic cancer (Review)
    Nnenna Elebo, Pascaline Fru, J. Omoshoro–Jones, Geoffrey Patrick Candy, Ekene Emmanuel Nweke · 2020 · Molecular Medicine Reports
86. Short-term outcomes after minimally invasive versus open pancreaticoduodenectomy in elderly patients: a propensity score-matched analysis
    Shih‐Min Yin, Yueh‐Wei Liu, Yu-Yin Liu, Chee‐Chien Yong, Chih‐Chi Wang, Weifeng Li, Cheng-Hsi Yeh · 2021 · BMC Surgery
87. Long Noncoding RNA DUXAP8 Promotes Pancreatic Carcinoma Cell Migration and Invasion Via Pathway by miR-448/WTAP/Fak Signaling Axis
    Jia-Rong Li, Ling Liu, Hui Luo, Ze-Guo Chen, Jian‐Hua Wang, Nian-Feng Li · 2021 · Pancreas
88. Evaluation of the Cancer Transition Theory in the US, Select European Nations, and Japan by Investigating Mortality of Infectious- and Noninfectious-Related Cancers, 1950-2018
    Omer Gersten, Magali Barbiéri · 2021 · JAMA Network Open
89. LINC00472 suppressed by ZEB1 regulates the miR‐23a‐3p/FOXO3/BID axis to inhibit the progression of pancreatic cancer
    Cong Bi, Gang Wang · 2021 · Journal of Cellular and Molecular Medicine
90. Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics
    Sophia G. Kisling, Gopalakrishnan Natarajan, Ramesh Pothuraju, Ashu Shah, Surinder K. Batra, Sukhwinder Kaur · 2021 · Cancer and Metastasis Reviews
91. Robust deep learning model for prognostic stratification of pancreatic ductal adenocarcinoma patients
    Jie Ju, Leonoor V. Wismans, Dana A. M. Mustafa, Marcel J. T. Reinders, Casper H.J. van Eijck, Andrew Stubbs, Yunlei Li · 2021 · iScience
92. Targeting the DNA damage response: PARP inhibitors and new perspectives in the landscape of cancer treatment
    Sofia Genta, Federica Martorana, Anastasios Stathis, Ilaria Colombo · 2021 · Critical Reviews in Oncology/Hematology
93. Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy
    Abhinav V. Reddy, Matthew Pierre Deek, Juan F. Jackson, Colin Hill, Shuchi Sehgal, Jin Peng He, Lei Zheng, Joseph M. Herman, Jeffrey John Meyer, Amol Kumar Narang · 2021 · Radiation Oncology
94. ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer
    Chen Zhou, Shoukang Li, Kaijian Bin, Gengdu Qin, Penglin Pan, Dianyun Ren, Yuhan Zhao, Wentao Xia, Jie Chen, Jiaying Liu et al. · 2022 · Cancer Letters
95. Single-centre comparison of robotic and open pancreatoduodenectomy: a propensity score-matched study
    Lapo Bencini, Federica Tofani, Claudia Paolini, Carla Vaccaro, Paolo Checcacci, Mario M. Annecchiarico, Luca Moraldi, Marco Farsi, Simone Polvani, Andrea Coratti · 2020 · Surgical Endoscopy
96. Downregulation of CDCA3 expression inhibits tumor formation in pancreatic cancer
    Renchao Zou, Zhi- Tang Guo, D. WEI, Z. T. SHI, Z. C. YE, G. ZHAI, C. ZHONG, Bo Tang, Liu-Fang Wang, Jiayun Ge · 2020 · Neoplasma
97. Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers
    Anita Alizadeh, Asiyeh Jebelli, Behzad Baradaran, Mohammad Ali Amini, Fatemeh Oroojalian, Mahmoud Hashemzaei, Ahad Mokhtarzadeh, Michael Richard Hamblin · 2020 · Gene
98. KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence
    Amintas, Samuel, Fernandez, Benjamin, Chauvet, Alexandre, Chiche, Laurence, Laurent, Christophe, Belleannée, Geneviève, Marty, Marion, Buscail, Etienne, Dabernat, Sandrine · 2022 · Scientific Reports
99. SPECT/CT Imaging, Biodistribution and Radiation Dosimetry of a 177Lu-DOTA-Integrin αvβ6 Cystine Knot Peptide in a Pancreatic Cancer Xenograft Model
    Sachindra Sachindra, Teresa Hellberg, Samantha Exner, Sonal Prasad, Nicola Beindorff, Stephan Rogalla, Richard H. Kimura, Sanjiv Sam Gambhir, Bertram J. Wiedenmann, Carsten Grötzinger · 2021 · Frontiers in Oncology
100. Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma
     Xiu Hu, Wei Chen · 2021 · World Journal of Clinical Cases